FDA Drug recall D-0223-2024
Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd
- FDA Drug
- Class II
- completed
- Published 2024-01-17
On 2024-01-17 the FDA classified a Class II recall of Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd by Dr Reddy S Laboratories, citing presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0223-2024 |
| Classification | Class II |
| Status | completed |
| Initiated | 2024-01-02 |
| Published | 2024-01-17 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | US |
Product
Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15
Reason
Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
Identifiers
| ndc | 55111-179-30 |
|---|---|
| ndc | 55111-179-15 |
| ndc | 55111-179-03 |
| ndc | 55111-179-10 |
| ndc | 55111-180-30 |
| ndc | 55111-180-15 |
| ndc | 55111-180-03 |
| ndc | 55111-180-10 |
| code_info | Lot #: T2304007, Exp 7/31/2026 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: completed.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0223-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.